| Name | MF-438 |
|---|---|
| Synonyms |
Steoyl-CoA Desaturase (SCD),inhibit,MF438,MF 438,MF-438,Inhibitor
3-(5-Methyl-1,3,4-thiadiazol-2-yl)-6-[4-[2-(trifluoromethyl)phenoxy]-1-piperidinyl]pyridazine 3-(5-Methyl-1,3,4-thiadiazol-2-yl)-6-[4-[2-(trifluoromethyl)phenoxy]-1-piperidinyl]pyridazine(MF-438) 2-methyl-5-[6-[4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl]pyridazin-3-yl]-1,3,4-thiadiazole MF-438, 10 mM in DMSO Pyridazine, 3-(5-methyl-1,3,4-thiadiazol-2-yl)-6-[4-[2-(trifluoromethyl)phenoxy]-1-piperidinyl] |
| Description | MF-438 is a potent and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor with an EC50 of 2.3 nM for rSCD1[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 2.3 nM (rSCD1)[1] |
| In Vivo | MF-438 exhibits an ED50 between 1 and 3 mg/kg in a mouse model[1]. |
| References |
| Molecular Formula | C19H18F3N5OS |
|---|---|
| Molecular Weight | 421.44 |